Honey treatment for frequent vaginal yeast infections
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This Phase 3 study tests a medical-grade honey product (L-Mesitran) to reduce symptoms from recurrent vaginal yeast infections. If you have frequent episodes, the honey treatment may help lower symptom flare-ups compared with usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a woman age 18 or older.
- You’ve had at least 3 yeast infection symptom episodes in the last year.
- At your visit, your yeast infection must be confirmed by symptoms and lab testing.
- You can understand the study, give consent, and follow study instructions.
- You are not pregnant (and you don’t plan pregnancy during the study) and you are not breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests occidiofungin, a new antifungal medication inserted into the vagina twice a week to prevent recurring yeast infections (vulvovaginal candidiasis). The goal is to see if this treatment can stop yeast infections from coming back.
This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.
This study tests whether a probiotic product (good bacteria) can help treat vulvovaginal yeast infections alongside standard care. You'll use the probiotic for a set period and report how your symptoms improve.
This trial tests if a new combination vaginal suppository works better than the standard one for women with yeast infections. It aims to see if adding lactulose to clotrimazole helps clear the infection faster or more completely.
This study tests a new antifungal medicine (oteseconazole) for women with a moderate to severe yeast infection. It aims to see if the drug works well and is safe.
This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.
Hear when a new Candidiasis, Vulvovaginal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.